CN1562357A - Medication use for external application of glucose-insulin-potassium polarization liquid for curing trauma and burn - Google Patents
Medication use for external application of glucose-insulin-potassium polarization liquid for curing trauma and burn Download PDFInfo
- Publication number
- CN1562357A CN1562357A CN 200410025977 CN200410025977A CN1562357A CN 1562357 A CN1562357 A CN 1562357A CN 200410025977 CN200410025977 CN 200410025977 CN 200410025977 A CN200410025977 A CN 200410025977A CN 1562357 A CN1562357 A CN 1562357A
- Authority
- CN
- China
- Prior art keywords
- wound
- insulin
- gik
- glucose
- burn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
An application of the polarized glucose-insulin-K (GIK) liquid in treating burn, wound and ulcer of diabetic is disclosed. It is also disclosed that high dosage results in higher curative effect.
Description
Technical field
The present invention relates to a kind of drug mixture and uses thereof, particularly a kind of known drug mixture---glucose-insulin-potassium (GIK) polarized solution, the new purposes in external application for curing wound, burn.
Background technology
In recent decades, the incidence rate of wound constantly increases, and dead and wounded number rises year by year, therefore is called as " flourishing social disease ".In China, wound rises to the 4th cause of the death after nineteen ninety-five, and is annual because of the about millions of people of wound casualties total number of persons.From the whole world, annual because of wound causes ten thousand people surplus the dead about 200, hinder the tens of millions of people.Scholarly forecast, 21 century the wound number may increase exponentially.Therefore, seeking the new technique of treatment wound, with the treatment level of further raising wound, is one of medical circle problem demanding prompt solution.
Wound (comprising burn) healing is the biological process of a complexity, comprise that blood clot forms, the gathering of inflammatory cell, epithelization, the secretion of wound circumference protease, collagen is synthetic and cicatrix generation, blood vessel and neuranagenesis etc., wherein relates to the synthetic and deposition etc. of propagation, differentiation, migration and the albumen substrate of cell.So promote cell proliferation and albumen substrate synthetic (tissue repair) to become one of main direction of studying of trauma care in recent years.The synthetic somatomedin of some artificial clone is used to Wound healing and bone regeneration recently, also there is the human transfection that the adenovirus treatment wound of growth factor gene is arranged, promote the expression of growth factor gene, thereby make that the content of somatomedin increases to some extent in the wound, play the effect of accelerating wound healing; In addition, the effect of stem cell in tissue repair also causes people's attention.Yet above-mentioned treatment means technical sophistication, expense costliness still can not become the conventional method of clinical treatment wound, and therefore, it is simple and easy, cheap to be badly in need of exploitation, and do not have the new trauma care method of special contraindication.
Summary of the invention
The objective of the invention is, a kind of known drug mixture is provided---the new purposes of glucose-insulin-potassium (GIK) polarized solution in external application for curing wound, burn.
GIK is used for the long history that auxiliary treatment ischemic heart desease (IHD) has year surplus in the of 40 as the cellular energy metabolism regulators.In recent years clinical trial confirms that repeatedly GIK can significantly reduce acute myocardial infarction (AMI) mortality in said patients; Recently insulin (a kind of classical hormone) Its Mechanisms is shown, insulin is except that promoting cellular energy metabolism and protein synthesis, also but active cell " existence signal (survival signaling) " system resists damage, anti-apoptosis, promotes cytothesis and existence.The applicant studies show that recently insulin is the crucial active substance among the GIK.
The known application of glucose-insulin-potassium (GIK) polarized solution:
1. stimulate myocardial cell Na
+-K
+-ATP enzyme promotes myocardial cell picked-up K
+Thereby the polarized state of stabilizing cell membrane reduces ARR generation.
2. provide more multipotency (glucose) to ischemic myocardium, and suppress ischemic myocardial cells by insulin and absorb and utilize free fatty acid, promote the myocardial cell picked-up and utilize glucose, finally promote the functional rehabilitation of ischemic myocardium.
Route of administration: intravenous drip
Dosage: glucose: 5%-25%, insulin: 8IU/L-25IU/L, potassium chloride (KCl): 26.5mmol/L.
As far back as nineteen sixty for middle and late stage, it has been recognized that the intravenous drip insulin can promote wound healing (WB GREGORY Jr. EFFECT OF INSULIN ON THE HEALING OF BONEWOUNDS IN ALBINO RATS.J Dent Res, May 1965; 44:487-92.SP Rosenthal.Acceleration of primary wound healing by insulin.Arch Surg, Jan 1968; 96:53-55.).Yet whole body is used insulin can make blood glucose, blood potassium obviously reduce (this is the reason that the clinician share glucose, insulin, potassium treatment IHD); Therefore, in the period of thereafter surplus in the of 30, though the insulin report useful to wound healing constantly arranged, quiet insulinize wound still rests on the level of zoopery and clinical trial, do not realized standardization and routinizes.
The applicant finds under study for action, is the local external application GIK of wound (burn) of animals such as rabbit, can obviously promote wound (burn) wound healing.
1. the local soak of insulin not only can promote epithelial cell, fibroblast proliferation, also can promote picked-up, utilization and the protein synthesis of wound local cells to glucose and potassium ion, increases the synthetic and deposition of collagen fiber, thereby quickens wound healing.In addition, insulin also can suppress tumor necrosis factor (TNF-α), il-1 β proinflammatory factors such as (IL-1 β), suppress leukocyte recruitment, the performance antiinflammatory action.
2. glucose external application wound surface can increase the local organization energy on the one hand and supply with, thereby promotes the granulation tissue growth; Can form height on the ulcer surface on the other hand and ooze environment, thereby suppress the growth and breeding of antibacterial, reduce infection chance; Also can absorb moisture in the wound tissue simultaneously, alleviate edema.
3. wound topical administration potassium ion can promote insulin to glycometabolic adjusting.
The specific embodiment
The present invention is described in further detail for experiment that provides below in conjunction with the inventor and result thereof.
1. external application medicinal liquid preparation:
GIK (KCl:40mmol/L～100mmol/L, solvent are aseptic double-distilled water for glucose: 25%-50%, insulin: 25IU/L-50IU/L)
2. the making of closed external application dressing:
Internal layer is drug of topical application layer (sterile gauze soaks into the GIK solution for preparing), is close to the skin ulcer covering weave; The middle level is water barrier (an aseptic vaseline oil yarn); Skin is a dry sterile gauze, amounts to 3 layers, and is fixing with wide adhesive plaster sealing around the dressing.
3. change dressings:
Common traumatic wounds: 1 time/day; After 3 days 1 time/2 days.
Burn wound: but dressing (1 time/day), or take the circumstances into consideration to adopt exposure method directly to smear, 2-3 time/day.
The applicant is by setting up wound and animal model of burn, and gives GIK external application for curing, obtains following result.
One, experimental technique:
1) sets up trauma model
10 of healthy adult male rabbits, 8% sodium sulfide is sloughed back wool, anaesthetizes with 3% pentobarbital sodium (30mg/kg) auricular vein.2cm is opened on each side, spinal column both sides, back, cuts off back one circular holostrome skin, reaches fascia deeply, and diameter 2.0cm causes 6 wound surface, and it is spaced apart 2.5cm, conventional hemostasis, the single cage raising in the back of waiting to wake up.6 place's wound surface are divided into normal saline (0.9%NaCl) matched group, low dosage GIK group and high dose GIK group, every group of 2 wound surface at random.Change dressings every day 1 time, the next day of changing into after 3 days 1 time, the 17th day entry wound healing number.
2) set up the burn model
10 of healthy adult male rabbits lose hair or feathers, anaesthetize the same.Each other 2cm that opens acts on skin 30 seconds for 90 ℃ with the electronic thermostatic scald apparatus in spinal column both sides, back, and causing diameter at the laboratory animal back is the circular dark II0 burn wound of 2.0cm (confirming through pathological section).Every side causes 3 wound surface, and it is spaced apart 2.5cm.6 place's wound surface are divided into normal saline (0.9%NaCl) matched group, low dosage GIK group and high dose GIK group, every group of 2 wound surface at random.Change dressings every day 1 time, the next day of changing into after 3 days 1 time, the 17th day entry wound healing number.
3) Wound cleansing
Clean wound with 3% hydrogen peroxide earlier, the back is cleaned and is dried with normal saline.
4) wound is changed dressings
A) external application medicinal liquid preparation:
GIK (KCl:40mmol/L～100mmol/L, solvent are aseptic double-distilled water for glucose: 25%-50%, insulin: 25IU/L-50IU/L)
B) making of closed external application dressing:
Internal layer is drug of topical application layer (sterile gauze soaks into the GIK solution for preparing), is close to the skin ulcer covering weave; The middle level is water barrier (an aseptic vaseline oil yarn); Skin is a dry sterile gauze, amounts to 3 layers, and is fixing with wide adhesive plaster sealing around the dressing.
C) change dressings: 1 time/day; After 3 days 1 time/2 days.
Two, result:
Experimental result sees table.
Table 1 GIK external application is to the influence of rabbit wound healing
Handle wound healing and count the wound surface number χ that do not heal
2Value P value
Normal saline 5 15
Low dosage GIK 12 8 5.013＜0.05
*
High dose GIK 18 2 4.800＜0.05
#
*P＜0.05 vs. normal saline processed group,
#P＜0.05vs. low dosage GIK processed group
Table 2 GIK external application is to the influence of rabbit burn wound healing
Handle wound healing and count the wound surface number χ that do not heal
2Value P value
Normal saline 3 17
Low dosage GIK 10 10 5.584＜0.05
*
High dose GIK 16 4 3.956＜0.05
#
*P＜0.05vs. normal saline processed group,
#P＜0.05vs. low dosage GIK processed group
Compare with normal saline, external application low dosage GIK can significantly promote rabbit wound (burn) wound healing, and the effect of short wound (burn) healing of high dose GIK is significantly better than low dosage GIK.This results suggest high dose GIK can accelerate wound healing speed, and potential clinical value is arranged.
In the past, though both at home and abroad relevant for the useful report of insulinize wound (burn) (with glucose, two kinds of drug combinations of insulin or with wherein a kind of), yet, definite proposition " polarized solution " external application for curing wound (burn) of nobody also.The applicant then emphasizes to have added potassium on above-mentioned both bases, has promptly constituted " polarized solution " that be used for treating coronary heart disease traditionally, and by external application for curing wound (burn).In addition, the applicant confirms first that by above-mentioned experiment high dose GIK urgees the effect of wound (burn) healing significantly better than low dosage GIK, and does not observe any toxic and side effects in the therapeutic process, uses high dose GIK external application for curing wound (burn) so advocate.
The scope of application of the present invention is external curing wound and wound surface (comprising burn, diabetes patient's intractable ulcer etc.), with wound, the burn acute stage GIK intravenous drip (systemic administration) associating result of use better.
The present invention is simple, cheap, and does not have special contraindication, can be used as extensive, conventional use such as large hospital, Branch Clinic.
Claims (2)
1. glucose-insulin-potassium (GIK) polarized solution promotes the medicinal usage in the tissue repair at external application for curing wound, burn.
2. application as claimed in claim 1, wherein the prescription of glucose-insulin-potassium (GIK) polarized solution is: glucose: 25%-50%, insulin: 25IU/L-50IU/L, KCl:40mmol/L～100mmol/L, solvent are aseptic double-distilled water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410025977 CN1255184C (en) | 2004-03-22 | 2004-03-22 | Medication use for external application of glucose-insulin-potassium polarization liquid for curing trauma and burn |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410025977 CN1255184C (en) | 2004-03-22 | 2004-03-22 | Medication use for external application of glucose-insulin-potassium polarization liquid for curing trauma and burn |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1562357A true CN1562357A (en) | 2005-01-12 |
| CN1255184C CN1255184C (en) | 2006-05-10 |
Family
ID=34480513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410025977 Expired - Fee Related CN1255184C (en) | 2004-03-22 | 2004-03-22 | Medication use for external application of glucose-insulin-potassium polarization liquid for curing trauma and burn |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1255184C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102218134A (en) * | 2011-05-31 | 2011-10-19 | 中国人民解放军第四军医大学 | L-arginine-glucose-insulin-potassium chloride composition and application thereof |
| WO2013111729A1 (en) * | 2012-01-23 | 2013-08-01 | 株式会社Cac | Pharmaceutical composition and quasi-drug cosmetic using same |
| CN106178076A (en) * | 2016-08-16 | 2016-12-07 | 中国人民解放军第五0中心医院 | A kind of preparation method of insulin gauze |
-
2004
- 2004-03-22 CN CN 200410025977 patent/CN1255184C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102218134A (en) * | 2011-05-31 | 2011-10-19 | 中国人民解放军第四军医大学 | L-arginine-glucose-insulin-potassium chloride composition and application thereof |
| WO2013111729A1 (en) * | 2012-01-23 | 2013-08-01 | 株式会社Cac | Pharmaceutical composition and quasi-drug cosmetic using same |
| TWI468184B (en) * | 2012-01-23 | 2015-01-11 | Cac Corp | Pharmaceutical composition and medical cosmetics |
| CN106178076A (en) * | 2016-08-16 | 2016-12-07 | 中国人民解放军第五0中心医院 | A kind of preparation method of insulin gauze |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1255184C (en) | 2006-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020101591A4 (en) | A thermosensitive gel, preparation method and application thereof | |
| ES2526640T3 (en) | Compositions to break and inhibit the reconstitution of the wound biofilm | |
| CN103083712A (en) | Stem cells or other bioactive substances doped surgical dressing | |
| CN112274571A (en) | Antibacterial hydrogel suitable for diabetic foot ulcer and preparation method thereof | |
| CN110974781A (en) | Gel for repairing skin wound | |
| CN1255184C (en) | Medication use for external application of glucose-insulin-potassium polarization liquid for curing trauma and burn | |
| CN111317855B (en) | Three-dimensional composite spongy structure body for promoting diabetic ulcer wound healing and method | |
| CN108354922B (en) | Medicinal preparation for treating diabetic chronic ulcer and preparation method thereof | |
| CN109432483B (en) | Medical dressing for accelerating wound healing and preparation method and application thereof | |
| CN111000794A (en) | Bletilla polysaccharide/bioglass temperature-sensitive gel and preparation method and application thereof | |
| RU2616239C2 (en) | Method for erosive and ulcerative skin lesions treatment | |
| CN103690903B (en) | A kind of Chinese traditional compound medicine for the treatment of the injuries such as burn and scald decubital ulcer | |
| RU2657806C2 (en) | Method for regional treatment of trophic ulcers | |
| CN102028875B (en) | Medicament for treating open wound and preparation method thereof | |
| CN1839898A (en) | Scar-free wet ointment for scald and burn and its preparation method | |
| CN1246021C (en) | Non-scar plaster for treating trauma and its preparing process and usage | |
| CN204275112U (en) | A kind of alginate medical dressing | |
| CN1314420C (en) | Stomatocace powder | |
| CN107485675A (en) | A kind of wound Regeneration and Repair removing necrosis, promoting granulation powder and preparation method and application method | |
| RU2307659C1 (en) | Method for producing means for treating infected injuries | |
| CN1698824A (en) | Externally applied plaster for treating local trauma | |
| CN1136904C (en) | Wound plaster of yannan Baiyao and its preparing method | |
| RU2342120C2 (en) | Method of contaminated wound treatment | |
| CN115531594B (en) | Wound healing dressing for diabetes and preparation method thereof | |
| CN1199666C (en) | Medicine 'Suyusan' for treating intractable ulcer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060510 |